GENE ONLINE|News &
Opinion
Blog

IPO
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Oxford Nanopore Soars on London Market Debut
2021-10-05
Cue Health’s $200 Million Nasdaq IPO: Where Will the Ball Roll Next?
2021-09-27
Oxford Nanopore Gears Up for Highly-Anticipated LSE IPO
2021-09-03
Singapore Exchange to Allow SPAC Listings on the Mainboard
2021-09-03
Revelation Goes the SPAC Way to list on Nasdaq
2021-08-31
Clarity Becomes ASX’s Biggest Ever Biotech IPO
2021-08-30
With Increasing Appeal for RNA Technology, Medford Startup Jumps on the SPAC Wagon to Go Public
2021-08-10
Bayer Spends $2 Billion to Acquire a Startup on the Brink of an IPO
2021-08-05
What are Investors Looking for in a Biotech Startup?
2021-07-27
Could this Biotech be the First Billion-Dollar Hong Kong Startup to Go Public?
2021-07-18
China’s Brii Bio Raises $319 million in the Hong Kong IPO
2021-07-16
Chinese Oncology Drugmaker to Raise over 600 Million in Hong Kong IPO
2021-06-22
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
IPO
Is the Path to Public Market Smooth? A Candid Discussion on SPACs
2021-06-15
1 2 3
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!